Dedicated To Improving Pharmaceutical Cold-Chain Distribution Practices
Login
User name:
Password:
Remember me 
View Article  The Cold Chain Chronicles: My version of "Deadliest Catch"

My son, Rory, and I recently returned from twelve days in Ireland. It rained only twice, once for seven days and once for five days. Where ever you go throughout Ireland, the people are always apologetic about the weather. It's as if they are embarrassed by it. But if you're going to Ireland for the weather, then you're going for the wrong reason - although, it helps to explain why the country is so lush and green, the people so pale, and why there is such an intense, natural inclination to drink so much.

The purpose of our trip was to inaugurate my son to the island home of his paternal Grandfather, and introduce him to his innumerable cousins on the Island of Arranmore, located in the remote northwest corner of County Donegal.

Arranmore is one of those places you can't get to by accident. It takes real determination and effort - but once there, it is like taking a giant step backwards in time. The rhythm of their days is still governed by the tide and Irish (Gaelic) is still spoken by all the residents and the preferred language of many. They still spade turf, and tend to flocks of sheep. There is no permanent Gardai Siocha (police) on the island and so, the pubs never close! The young people can often be seen walking the hills at daybreak, making their way home from the island's popular disco.

It is a beautiful, rugged and peaceful place where fishing was once a major industry. No more. The shoals of herring are gone, the Cod, too. The North Atlantic Salmon have dwindled to the point where the government has intervened and taken over their management. Salmon fishing is now illegal in Irish waters.

But there are a few who continue to comb the rocky harbors of the Donegal coast for European Lobster and Brown Crab. I jumped at the invitation to accompany a long-time friend and island resident, Jerry Early, to "pull pots" one morning. We set out in a light drizzle (did I mention it rained a lot?) and harvested several lobster from stringers Jerry had set the day before in coves on the north side of the island. I found it to be back-breaking and invigorating work, but handled with effortless routine by my fisherman friend. It was one of those once-in-a-lifetime experiences and an incredible education.

 Before docking, my son took a few pictures. I  didn't notice until I was looking through the pictures yesterday, that in the background of one of the photos is a 20 foot insulated sea container - the kind pharmaceutical companies consign for temperature-sensitive ocean shipments. Jerry uses it to store his fishing gear and bait. Where it came from and how it got to such a remote location, I haven't a clue and I didn't ask. The thrifty and ingenious islanders make practical use of just about everything. I thought the accidental photo qualified for a "cooler head sighting".

Some photos of the adventure are attached. (Click on the paper clip icon below). The final photo shows me and Jerry rewarding ourselves for the days' work by engaging in some traditional Irish craic in one of the quaint pubs on Arranmore.

6 Attachments
View Article  IATA Fills Remaining Time & Temperature Task Force Positions

The International Air Transport Association (IATA) Live Animals & Perishables Board has completed its six week evaluation process of candidates from supporting industries to round out its Time & Temperature Task Force (TTTF). The voluntary 12 member task force was put in place by IATA to improve the logistics of temperature sensitive healthcare freight. The call for candidates in April resulted in an overwhelming response from all quarters of the biopharmaceutical and transportation industries.

The TTTF's first order of business is to establish working groups to categorize and address the '26 points of concern' developed by the cross-industry delegates at the World Cargo Symposium in Rome, Italy last March.

Three working groups have been established whose volunteers from various sectors of the industry will work together to "establish minimum standards for transport and handling of healthcare freight."

The working groups will begin working on the following three interconnected topics:

1. Revising Chapter 17 of the Perishable Cargo Regulations, making it more practical for the user,

2. Establish a Quality Systems Manual (QSM)

3. Work with other organizations such as PCCIG and USP to work toward a consensus for a handling label for time and temperature sensitive healthcare freight.

The task force will meet with the Live Animals & Perishables Board of IATA in Montreal, Canada, in October to report its progress.

 

View Article  Advanced Degrees: Defining Cold

My regularly scheduled column in Contract Pharma can be read on-line here.

This month, a discussion on the definition of cold, how it varies among industries and the possible risks and implications this has for temperature-sensitive healhcare freight in distribution.

View Article  Symposium on Maintaining Integrity of International Cold-Chain Shipments Includes a Rare Look at 747 Cargo Operations

Schenker/BAX Global, the global transportation and logistics provider, is hosting a symposium on new strategies for maintaining the integrity of biopharmaceutical cold-chain shipments on June 19, 2008 in suburban Detroit, MI.

The one day event includes three round table discussions moderated by Nick Basta, Editor, Pharmaceutical Commerce Magazine. I have been invited to participate on the panel to discuss the challenges of moving temperature-controlled heavy freight internationally. The panel also includes: Doug Britton (Director, TSA Cargo), Pete Chevoit (VP Corporate Security, Schenker/BAX), Henry Ames (Director of Marketing & Business Development, Sensitech), Maurice Barakat (President & CEO, TCP Reliable), Curt Cole (CEO, Total Quality Inc.), and Malcolm Heath (Exec. VP Airfreight Operations, Schenker).

The discussion will center around large scale cargo perspectives, and will include a pre-arranged trip to the Shenker/BAX hub to observe their 747 F operation. The end goal is to link in a controlled room temperature environment USA and Europe via scheduled 747 F service, using best in class providers in data collection, measurement, packaging, ground services.

To obtain an invitation to this event, contact Bob Gahan at BAX Global. His contact information, along with more specific details (including a unique dinner guest speaker) are attached.

(Click in the attached file below).

 

1 Attachments
View Article  Global Pharma Sales Grow in 2007, but Slows in U.S., Biotechs Remain Steady

IMS Health's annually published Market Performance Review reported its biopharmaceutical market figures this month for 2007. They state that global pharma sales reached a record $712 Billion, up 6.4%, with U.S. sales, which constitutes 40.2% of the overall market, at $286.5 Billion, up only 3.8%, contributing only 25% of the global growth, the lowest fraction ever, and the slowest growth rate here since 1961. They attribute this modest growth to patent expirations,  more generics, (now 65.7% of overall pharmaceutical sales), fewer and more narrowly focused novel medications, closer scrutiny over safety issues, and lack of new product launches.

European sales were $221.6 Billion with the largest growth in Russia, (20.2%) and Turkey (17.2%).

Japan rose 3.6% in 2007 to 65.2 Billion and the rest of Asia (excluding Japan but including Australia and New Zealand) continued its strong growth, up by 13.3%, at $78 Billion (11% of the global market). This was followed closely by Latin America, up 11.6% to $11.1 Billion.

Globally, Biotechs grew at 9% while specialties grew at 10% and oncology drugs at 14%.

IMS projects a compounded growth rate between 3-6% through 2012.